Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.
Press releases published on April 27, 2025
Le lendemain des élections fédérales, 500 leaders en innovation se réunissent pour dessiner l'avenir économique du Canada
GlobeNewswire
·
April 27, 2025
OTTAWA, Ontario, 27 avr. 2025 (GLOBE NEWSWIRE) -- Le matin du 29 avril, au lendemain des élections fédérales canadiennes, plus de 500 entrepreneurs, investisseurs, créateurs d'emplois et leaders en innovation de partout au Canada se réuniront en face de la …
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TBBK
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Bancorp, Inc. (NASDAQ: TBBK) between January 25, 2024 and March 4, 2025, both dates inclusive (the “Class Period”), …
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
GlobeNewswire
·
April 27, 2025
Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ABP-102/CT-P72 HER2-positive cancers represent up to 30 …
JETOUR Showcases Advanced Off-Road Technology at Auto Shanghai 2025 with Global Media Test Drive Event
GlobeNewswire
·
April 27, 2025
Shanghai, April 27, 2025 (GLOBE NEWSWIRE) -- JETOUR, the innovative auto brand, hosted an test drive event for over 200 global media and influencers from the Middle East, South America, Africa, Asia-Pacific, and the CIS region. The event, held at the …
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, inclusive (the “Class Period”), of …
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Perpetua Resources Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PPTA
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perpetua Resources Corp. (NASDAQ: PPTA) between April 17, 2024 and February 13, 2025, both dates inclusive (the “Class …
APP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
GlobeNewswire
·
April 27, 2025
SAN DIEGO, April 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 27, 2025
REDWOOD CITY, Calif., April 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced new clinical data for …
SWKS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Skyworks Solutions, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
GlobeNewswire
·
April 27, 2025
SAN DIEGO, April 27, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
GlobeNewswire
·
April 27, 2025
STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for …
Risk Strategies acquires GMC Advisors, LLC
GlobeNewswire
·
April 27, 2025
BOSTON, April 27, 2025 (GLOBE NEWSWIRE) -- Risk Strategies, a leading North American specialty insurance brokerage, risk management and consulting firm, announced today that it has acquired GMC Advisors, LLC., based in Houston. Terms of the deal were not …
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 27, 2025
CORAL GABLES, Fla., April 27, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
ALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics (NASDAQ:ALDX) is being Investigated after 75% Stock Drop – Investors are Urged to Contact BFA Law
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
VTRS SHAREHOLDER REVIEW: Viatris Inc. (NASDAQ:VTRS) was Sued for Fraud after 15% Stock Drop – Investors are Urged to Contact BFA Law
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
FLNC SHAREHOLDER REVIEW: Fluence Energy, Inc. (NASDAQ:FLNC) was Sued for Fraud after 46% Stock Drop – Investors are Urged to Contact BFA Law
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
TBBK SHAREHOLDER REVIEW: The Bancorp, Inc. (NASDAQ:TBBK) was Sued for Fraud after 28% Stock Drop – Investors are Urged to Contact BFA Law
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …